FIGURE 4.

Prevalence and proportion of each respiratory virus identified in COVID‐19 patients. (a), Pooled prevalence of each respiratory virus identified in co‐infected COVID‐19 patients based on the number of tests performed for each pathogen. Each line segment's midpoint exhibited the prevalence estimation; the line segment length presents 95% confidence intervals. (b), Number of respiratory viral pathogens detected in COVID‐19 patients, as a proportion of the total number of detections (N = 749). Abbreviations: FLU, Human influenza virus; FLUA, Human influenza virus A; FLUB, Human influenza virus B; HPIV, Human parainfluenza virus; HPIV‐1, Human parainfluenza virus 1; HPIV‐2, Human parainfluenza virus 2; HPIV‐3, Human parainfluenza virus 3; HPIV‐4, Human parainfluenza virus 4; HCoV, Human respiratory coronavirus; HCoV‐229E, Human respiratory coronavirus 229E strain; HCoV‐NL63, Human respiratory coronavirus NL63 strain; HCoV‐OC43, Human respiratory coronavirus OC43 strain; HCoV‐HKU1, Human respiratory coronavirus HKU1 strain; HAdV, Human adenovirus; HRSV, Human respiratory syncytial virus; RV, Human rhinovirus; EV, Human enterovirus; HBoV, Human bocavirus; HMPV, Human metapneumovirus; MERS‐CoV, Middle East respiratory syndrome‐related coronavirus; HPeV, Human parechovirus